Introduction
Fused heterocyclic compounds containing nitrogen atoms are an important class of natural and synthetic products [1] [2] [3] [4] [5] [6] [7] [8] . The bicyclic imidazo [2,1-b] [1, 3, 4] thiadiazole system, composed of imidazole and 1,3,4-thiadiazole moieties [9] , is present in natural products [10] including alkaloids [11] and in pharmaceuticals [12] . Applications in oncology [13] , infectiology [14] , cardiovascular diseases [15] or central nervous system neurodegenerative diseases [16] have been reported. Imidazo [2,1-b] [1, 3, 4] thiadiazoles exhibit biological activities including antibacterial [17] , antifungal [18] , antitubercular [19] , anti-inflammatory [20] and anticancer [21] properties. Some drugs of this class are displayed in Figure 1 .
The outstanding potential of one-pot multicomponent reactions (MCRs) is the synthesis without separating intermediate species, purification or swapping the solvent [22] [23] [24] . In addition, such reactions often are characterized by extraordinary chemo-and regioselectivity [25, 26] . Accordingly, industrial and academic researchers have increasingly focused on the development of MCRs [27] . The use of water as a green solvent for the synthesis of heterocyclic compounds is also one of the goals of the chemists [28, 29] . Unfortunately, imidazo [2,1-b] [1, 3, 4] thiadiazoles have been synthesized by using reactions in organic solvents [30] [31] [32] [33] [34] [35] [36] .
Results and discussion
In continuation of our efforts on synthesis of new heterocyclic compounds by using MCRs [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] , herein we report the efficient synthesis of 5-(2-hydroxy-4-oxoquinolin-3(4H)-ylidene)-6-aryl-5,6-dihydroimidazo [2,1-b] [1, 3, 4] thiadiazol-7-ium hydroxides 4a-k by a one-pot three-component reaction (TCR) of aryl glyoxal monohydrates 1a-k, quinoline-2,4-diol 2 and 5-ethyl-1,3,4-thiadiazol-2-amine 3 in water under reflux conditions. The synthesized new compounds are interesting from the biological and pharmaceutical points of view (Scheme 1). The starting aryl glyoxal monohydrates containing electron-donating and electron-withdrawing substituents were prepared by oxidation of the corresponding acetophenones with SeO 2 in H 2 O/dioxane under reflux conditions [48] . This work started with the examination of a one-pot TCR using aryl glyoxal monohydrate 1a (1.00 mmol), quinoline-2,4-diol 2 (1.00 mmol) and 5-ethyl-1,3,4-thiadiazol-2-amine 3 (1.00 mmol). First, this model reaction was attempted in the absence of any catalyst in different organic solvents, but no product formation was observed after 24 h of stirring under reflux. In a similar way, in the presence of basic catalysts such as K 2 CO 3 , 1,4-diazabicyclo[2.2.2]octane (DABCO) and Et 3 N in organic solvents, no product was formed even after 18 h at elevated temperatures. The use of acidic catalysts including L-proline, InCl 3 , FeCl 3 and ZnO in organic solvents also failed to produce the desired product 4a. Finally, in the presence of sulfamic acid as a catalyst in water under reflux, the desired product 4a was obtained in a 27% yield. It was found that under the optimized conditions the reaction leading to 4a is best conducted in water under reflux in the presence of the catalyst composed of sulfamic acid (25 mol%) and triethylamine (TEA, 10 mol%). Under these conditions, the desired product 4a was synthesized in an 87% yield after 3 h of reflux. The yield of 4a was 40% for the reaction conducted at room temperature for 24 h. The reaction mixture was alkaline (pH = 8) after addition of TEA, became acidic (pH = 3) after addition of sulfamic acid and remained acidic during heating for 3 h.
In order to assess the scope of the reaction, a series of aryl glyoxal monohydrates 1b-k were allowed to react with 2,4-quinolinediol 2 and 5-ethyl-1,3,4-thiadiazol-2-amine 3 under the optimized conditions. In all cases, the expected imidazo [2,1-b] [1, 3, 4] thiazoles 4b-k were obtained in high yields (Scheme 1).
The given structures of all synthesized imidazo [2,1-b] [1, 3, 4] thiadiazol-7-ium hydroxide derivatives 4a-k were confirmed by analysis of their A mechanism for the synthesis of compounds 4a-k is suggested in Scheme 2. The first steps are trimethylamine-mediated conversion of the aryl glyoxal monohydrates 1a-k to the aryl glyoxals by dehydration and ionization of quinoline-2,4-diol 2 to its enolate ion. The Knoevenagel condensation between the two reactants mentioned leads to the formation of an intermediate product A. The regioselective Michael addition of 5-ethyl-1,3,4-thiadiazol-2-amine 3 to A in the presence of sulfamic acid leads to the formation of an intermediate product B, which is subsequently converted to the observed hydroxides 4a-k by intramolecular condensation, followed by keto-enol tautomerization (Scheme 2).
Conclusions
A green, efficient method for the synthesis of imidazo[2,1-b] [1, 3, 4] thiadiazol-7-ium hydroxide compounds 4a-k, via a one-pot TCR of aryl glyoxals, quinoline-2,4-diol and 5-ethyl-1,3,4-thiadiazol-2-amine in the presence of TEA (10 mol%)/sulfamic acid (25 mol%) in water was developed. The simple work-up, operational simplicity, regioselectivity and high yields are the main advantages of this protocol.
Experimental
All chemicals were obtained from Arcos and Merck companies and were used without further purification. Melting points were determined on a Philip Harris C4954718 apparatus and are uncorrected. The progress of the reactions were monitored by thin layer chromatography (TLC) on Merck's silica gel plates. Infrared spectra were recorded on a Thermo Nicolet Nexus 670 FT-IR instrument using KBr discs. 1 H and 13 C NMR spectra were recorded on a Bruker Advance AQS 300 MHz spectrometer in DMSO-d 6 at 300 MHz and 75.5 MHz, respectively.
General procedure for the synthesis of 2-ethyl-5-(2-hydroxy-4-oxoquinolin-3(4H)-ylidene)-6-aryl-5,6-dihydroimidazo[2,1-b][1,3,4]thiadiazol-7-ium hydroxides 4a-k
A suspension of quinoline-2,4-diol 2 (0.161 g, 1.00 mmol) and TEA (10 mol%) in water (5 mL) was stirred under reflux for 10 min to make a solution. Aryl glyoxal 1a-k (1.00 mmol), 5-ethyl-1,3,4-thiadiazol-2-amine 3 (0.129 g, 1.00 mmol) and sulfamic acid (25 mol%) were added to the solution and the mixture was stirred under reflux for the period of time indicated below. The progress of the reaction was monitored by TLC eluting with chloroform/methanol (10:1). After completion of the reaction, the residue of the product 4a-k was filtered and washed with water. 3(4H)-ylidene)-5,6-dihydroimidazo[2,1-b][1,3,4 193.7, 169.0, 162.3, 161.9, 143.2, 138.8, 133.3, 130.0, 129.2, 128.2,  127.0, 125.3, 122.8, 121.0, 116.5, 114.6, 111.2, 25.1, 23 -6-(4-hydroxy-3-methoxyphenyl)-5-(2-hydroxy-4-oxoquinolin-3(4H)-ylidene)-5,6-dihydroimidazo[2,1-b][1,3,4 5-(2-hydroxy-4-oxoquinolin-3(4H)-ylidene)-6-(4-nitrophenyl)-5,6-dihydroimidazo[2,1-b][1,3,4 
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